FDA inspection
Jilin Shulan Synthetic Pharmaceutical Co. Ltd.: FDA inspection ending Nov 10, 2017
FDA inspection 1032074 · Official Action Indicated (OAI) · Jilin
Key facts
| Inspection ID | 1032074 |
|---|---|
| Firm | Jilin Shulan Synthetic Pharmaceutical Co. Ltd. |
| FEI number | 3003091092 |
| Address | No. 2066 Peoples Main Road, Shulan |
| City | Jilin |
| Country | China |
| Fiscal year | 2018 |
| Inspection end date | Nov 10, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 546328 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data